Vicarious Surgical Raises An Additional $13.2 Mil in Capital

CathWorks FFRangio™ System Receives National Reimbursement Approval in Japan

CathWorks announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) has approved the application to provide reimbursement for the CathWorks FFRangio™ System,...

Levine Leichtman Capital Partners Sells FlexXray

Levine Leichtman Capital Partners ("LLCP"), a Los Angeles-based private equity firm, announced today that it has sold its portfolio company FlexXray Holdings, LLC ("FlexXray" or...

Vicarious Surgical reports funding was led by Philip Liang of E15 Capital.

Vicarious Surgical added Philip Liang and Ric Fulop to their Board of Directors.

“As we approach clinical use with our first product, I am thrilled to bring on Phil, E15 Capital, and the experience of their team,” said Adam Sachs, CEO of Vicarious Surgical. “Adding both the capital and E15’s experience in this industry will be invaluable to our success. This is a great milestone and a strong start to the next phase of our growth as a company.”

In addition to E15 Capital, the new round of funding includes investment from existing investors Bill Gates, Khosla Ventures, Innovation Endeavors, and AME Cloud Ventures. Vicarious Surgical plans use the proceeds to further develop its revolutionary new surgical robotics platform.

“We couldn’t be more excited to join Adam and the Vicarious Surgical team in their mission to offer high-quality surgical care across the world,” said Phillip Liang, Managing Director of E15 Capital. “I’ve been incredibly impressed with the progress the Vicarious Surgical team has made. As an investor in surgical robotics, this is the type of company and founder you hope to find. I am excited to bring our industry experience to the existing team and to drive this company towards helping patients, surgeons, and hospitals across the world.”

Ric Fulop is the founding CEO of Desktop Metal and brings his experience building two unicorn startups to the Vicarious Surgical team as a member of the Board of Directors. “I’m proud to be part of such an incredible team, and excited to help their mission to improve patient care, surgeon experience, and reduce cost from the healthcare system.”



Asensus Surgical Appoints Two New Board Members

Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced the expansion of its Board of Directors, appointing...

Our Sister Publication: Biotechnology News Magazine

Subscribe to Medical Device News Magazine here.